All case studies

Highlights

We focus our innovation on the factors that matter most — accelerating time to market, reducing costs and enhancing quality. Learn more about how we've helped clients meet and exceed their goals in this selected library of case studies.

Proactive patient retention strategy in a GLP-1 RA trial

Explore how ICON successfully supported a sponsor’s cardiovascular outcome trial for a GLP-1 receptor agonist with 9,900+ patients with type 2 diabetes and maintained a retention rate of 97% over 7 years.

A small biotech success story

A small US-based biotech company was in a race to be the first to market with their lead targeted oncology product.

FSP partnership - sustained efficiency and ongoing innovation

The implementation of an FSP model across our partner's project management function, led to 20% cost efficiences and a 30% reduction in client burden.

By taking a site and patient-centric approach, and leveraging advanced tools and real-time data insights, we maximise patient access, recruitment, and retention—ensuring that every trial is conducted with efficiency, agility, and a commitment to improving patient outcomes.

All case studies

Filter our case studies by categories, selecting amongst our broad range of solutions.

Comprehensive due diligence

ICON was approached by a customer seeking our expertise in conducting drug asset evaluation consulting services. The client looked to evaluate pharmaceuticals suitable for in-licensing or co-development, placing particular emphasis on autoimmune diseases.

Enhancing strategic partnerships through streamlined EDC build processes

ICON collaborated with the trial sponsor to identify opportunities for improving specific processes related to electronic data capture (EDC) build for select studies.
Through a comprehensive SWOT analysis of a suite of studies, ICON identified areas for study build process improvements across the entire portfolio.

Delivering high quality at low cost

We created a more sustainable organisational design for our partner, within their Data Management and Biostatistics functions, resulting in a 56% cost saving.

FSP partnership - sustained efficiency and ongoing innovation

The implementation of an FSP model across our partner's project management function, led to 20% cost efficiences and a 30% reduction in client burden.

Vendor consolidation with a top 10 pharma company

Read more about how we consolidated over 340 site management resources, from 70 vendors, across 30 countries resulting in a 91% reduction in client burden.

Data analytics enabled FSP solutions

In a multi-vendor FSP model for clinical monitoring, the client required the capability to aggregate and analyse data internally across all FSP providers.

Promoting growth and reducing turnover through rapid and efficient resource allocation

Due to unprecedented resourcing needs prompted by the COVID-19 pandemic, our large pharma partner required rapid and efficient resource allocation in an FSP model to reduce turnover and promote growth.

Virtual Development Model

A venture-backed biopharmaceutical company focused on therapies for rare diseases needed to accelerate late-stage development and commercialization. ICON provided technical and commercial assessments, collaborating closely to simplify the development program and develop ePROs and a novel biomarker approach for the rare disease asset.

Cardiac imaging and monitoring support for PAH trial

ICON provided a large pharma sponsor with consistent, accurate ECG and ECHO modality imaging, contributing to a breakthrough pulmonary arterial hypertension treatment.

Long-term benefits of FSP partnerships in biometrics

The sponsor sought out ICON’s data management resources for their support in several international and complex programs using our FSP model across several therapeutic areas: oncology, neurology, infectious disease, endocrinology, and nephrology.

Creating an industry-leading clinical operations risk management function

Discover how ICON's cross-functional collaboration led to to creation of an industry-leading clinical risk management platform.

Out-performing ambitions with strategic capacity management

Explore how we built a dedicated global infrastructure of functional hubs, reducing the cost per FTE by over 20% and resulting in 20% productivity savings.

Solutions case studies

Our solutions span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs. Explore our work in the different aspects of our solutions.

Let's collaborate

Discover how ICON's expertise transforms clinical trials.

Blogs

Stay informed with ICON's expert insights on clinical trials, regulatory changes, and industry trends. Our blogs provide practical advice, innovative solutions, and thought leadership from global experts.

News

Stay updated with our latest news on partnerships, financial results, technological advancements, and industry insights.

Insights

Explore ICON's expert analysis and practical advice on the latest operational, regulatory, technological and economic challenges in clinical research. Our insights provide thought leadership and innovative solutions to transform trials.

Case studies

Highlights

Proactive patient retention strategy in a GLP-1 RA trial

A small biotech success story

FSP partnership - sustained efficiency and ongoing innovation

All case studies

Comprehensive due diligence

Enhancing strategic partnerships through streamlined EDC build processes

Delivering high quality at low cost

FSP partnership - sustained efficiency and ongoing innovation

Vendor consolidation with a top 10 pharma company

Data analytics enabled FSP solutions

Promoting growth and reducing turnover through rapid and efficient resource allocation

Virtual Development Model

Cardiac imaging and monitoring support for PAH trial

Long-term benefits of FSP partnerships in biometrics

Creating an industry-leading clinical operations risk management function

Out-performing ambitions with strategic capacity management

Solutions case studies

Let's collaborate

Blogs

News

Insights